|Articles|June 29, 2023
DIA 2023: Keeping Patients Informed
Advertisement
In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Jean Sposaro, program lead, TransCelerate BioPharma, and director, global drug development operations industry collaborations, Bristol Myers Squibb discusses riaising awareness about clinical trials and increasing the public's trust in them.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Where AI Is Delivering Real Value in Clinical Trial Payments Right Now
2
Navigating the Adoption of Biomarker-Informed Trial Enrollment Beyond Oncology
3
ACT Brief: AI in Invoice Processing, Botanical Medicines and FDA Pathways, and Connected Trial Finance Systems
4
How Urgent Is the Site Payment Problem, and Is the Industry Finally Taking It Seriously?
5